Prenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARγ Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain Neurons

Mol Neurobiol. 2019 Jul;56(7):4820-4837. doi: 10.1007/s12035-018-1401-5. Epub 2018 Nov 6.

Abstract

The UV absorber benzophenone-3 (BP-3) is the most extensively used chemical substance in various personal care products. Despite that BP-3 exposure is widespread, knowledge about the impact of BP-3 on the brain development is negligible. The present study aimed to explore the mechanisms of prenatal exposure to BP-3 in neuronal cells, with particular emphasis on autophagy and nuclear receptors signaling as well as the epigenetic and post-translational modifications occurring in response to BP-3. To observe the impact of prenatal exposure to BP-3, we administered BP-3 to pregnant mice, and next, we isolated brain tissue from pretreated embryos for primary cell neocortical culture. Our study revealed that prenatal exposure to BP-3 (used in environmentally relevant doses) impairs autophagy in terms of BECLIN-1, MAP1LC3B, autophagosomes, and autophagy-related factors; disrupts the levels of retinoid X receptors (RXRs) and peroxisome proliferator-activated receptor gamma (PPARγ); alters epigenetic status (i.e., attenuates HDAC and sirtuin activities); inhibits post-translational modifications in terms of global sumoylation; and dysregulates expression of neurogenesis- and neurotransmitter-related genes as well as miRNAs involved in pathologies of the nervous system. Our study also showed that BP-3 has good permeability through the BBB. We strongly suggest that BP-3-evoked effects may substantiate a fetal basis of the adult onset of neurological diseases, particularly schizophrenia and Alzheimer's disease.

Keywords: Autophagy; BP-3; Benzophenone-3; Neuronal cell; Prenatal exposure; miRNA.

MeSH terms

  • Animals
  • Autophagosomes / drug effects
  • Autophagosomes / metabolism
  • Autophagy / drug effects*
  • Autophagy / genetics
  • Benzophenones / administration & dosage
  • Benzophenones / toxicity*
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / pathology
  • Brain / pathology*
  • Embryo, Mammalian / cytology
  • Epigenesis, Genetic* / drug effects
  • Female
  • Histone Acetyltransferases / metabolism
  • Histone Deacetylases / metabolism
  • Mice
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Neurogenesis / drug effects
  • Neurogenesis / genetics
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / pathology*
  • Neurotransmitter Agents / metabolism
  • PPAR gamma / metabolism*
  • Permeability
  • Pregnancy
  • Prenatal Exposure Delayed Effects / genetics*
  • Prenatal Exposure Delayed Effects / pathology*
  • Protein Processing, Post-Translational / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Retinoid X Receptors / metabolism
  • Signal Transduction / drug effects
  • Sirtuins / metabolism
  • Sumoylation

Substances

  • Benzophenones
  • MicroRNAs
  • Neurotransmitter Agents
  • PPAR gamma
  • RNA, Messenger
  • Retinoid X Receptors
  • oxybenzone
  • Histone Acetyltransferases
  • Sirtuins
  • Histone Deacetylases